Impact of Pregnancy-Associated Plasma Protein-A Deletion on the Adult Murine Skeleton
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 23 (5), 655-662
- https://doi.org/10.1359/jbmr.071210
Abstract
The metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A) functions to enhance local insulin-like growth factor (IGF)-I bioavailability through cleavage of inhibitory IGF binding proteins. Because IGF-I is an important regulator of skeletal growth and remodeling and PAPP-A is highly expressed by osteoblastic cells, we hypothesized that, in the absence of PAPP-A, bone physiology would be compromised because of a blunting of local IGF-I action even in the presence of normal circulating IGF-I levels. pQCT, muCT, histomorphometry, and mechanical strength testing were performed on bones from PAPP-A knockout (KO) mice and wildtype (WT) littermates at 2-12 mo of age. IGF-I levels and bone formation and resorption markers were determined in sera from these animals. Volumetric BMD in PAPP-A KO mice measured by pQCT at the femoral midshaft, which is primarily cortical bone, was 10% less than WT at 2 mo. This difference was maintained at 4, 6, and 12 mo. Cortical thickness at this site was similarly decreased. On the other hand, trabecular bone at the distal femur (pQCT) and in the tibia (muCT) showed age-progressive decreases in bone volume fraction in PAPP-A KO compared with WT mice. Tibial muCT indicated a 46% relative decrease in trabecular bone volume/total volume (BV/TV) and a 28% relative decrease in trabecular thickness in PAPP-A KO compared with WT mice at 6 mo. These trabecular deficiencies in PAPP-A KO mice corresponded to a weakening of the bone. Serum markers and bone histomorphometry indicated that the primary impact of PAPP-A is on skeletal remodeling resulting in a state of low-turnover osteopenia in adult PAPP-A KO mice. Circulating IGF-I levels were not altered in PAPP-A KO mice. PAPP-A is a bone growth regulatory factor in vivo and, in its absence, mice show skeletal insufficiency in mass, density, architecture, and strength. The data suggest a primary role for PAPP-A in modulating local IGF bioavailability for trabecular bone remodeling.Keywords
This publication has 40 references indexed in Scilit:
- A Chromosomal Inversion within a Quantitative Trait Locus Has a Major Effect on Adipogenesis and OsteoblastogenesisAnnals of the New York Academy of Sciences, 2007
- Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor?Growth Hormone & IGF Research, 2007
- Pregnancy-Associated Plasma Protein-A Increases Osteoblast Proliferation in Vitro and Bone Formation in VivoEndocrinology, 2006
- Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodelingBone, 2006
- Pregnancy‐associated plasma protein‐A proteolytic activity in rat vertebral cell cultures: Stimulation by dexamethasone–a potential mechanism for glucocorticoid regulation of osteoprogenitor proliferation and differentiationJournal of Cellular Physiology, 2005
- Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5Bone, 2005
- Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal developmentDevelopment, 2004
- Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnoverJCI Insight, 2000
- Studies on the Role of Human Insulin-like Growth Factor-II (IGF-II)-Dependent IGF Binding Protein (hIGFBP)-4 Protease in Human Osteoblasts Using Protease-Resistant IGFBP-4 AnalogsJournal of Bone and Mineral Research, 1999
- Insulin-like growth factor binding protein proteolysis in bone cell modelsProgress in Growth Factor Research, 1995